Liraglutide Cost: List Price, Coverage, and Savings Factors

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub — plain-language guidance on GLP-1 therapy, metabolic health, and the genetics behind individual response.

Liraglutide is one of the older names in the GLP-1 receptor agonist family, and its cost remains a frequent search as of April 2026. What a person pays each month is rarely a single tidy figure — it is the product of insurance design, the indication written on the prescription, savings-card eligibility, and the pharmacy that fills it. This guide walks through the published list price, how coverage bends that number, and why the sticker figure online seldom matches the counter total.

What liraglutide costs before insurance

At U.S. list price as of April 2026, liraglutide runs approximately $815 per month according to Novo Nordisk published pricing. Treat that as a ceiling, not a forecast. List price is the pre-negotiation starting point that comes before rebates, plan discounts, manufacturer cards, and pharmacy adjustments — almost no insured patient pays the raw number, and the real total swings with your plan, formulary, and prescribed indication.

How coverage reshapes the number

Whether a commercial plan pays toward liraglutide hinges on the indication and on that plan's formulary and prior-authorization rules. Coverage for type 2 diabetes is common among commercial plans. Coverage tied to chronic weight management is far less predictable: it is frequently gated behind BMI-based prior authorization, and some plans carve weight indications out entirely. Medicare, as of April 2026, does not pay for FDA-approved weight-management drugs for weight alone, though certain cardiovascular indications are covered. Confirm specifics with your own plan.

Savings cards and pharmacy coupons

Manufacturer programs

Novo Nordisk runs a savings-card program that can meaningfully cut monthly out-of-pocket cost for eligible commercially-insured patients. Government coverage — Medicare, Medicaid, TRICARE — is typically excluded, and the cards carry monthly and annual caps that change over time. Verify current terms on the manufacturer site before you fill.

Third-party discounts

Independent platforms such as GoodRx and SingleCare publish coupon prices that differ pharmacy to pharmacy. They are worth comparing, but the amount you save varies by location and is not guaranteed from one fill to the next.

The compounding chapter of 2024–2025

While the FDA listed semaglutide and tirzepatide as being in shortage, 503A compounding pharmacies were permitted to prepare compounded versions of those molecules. The agency declared the semaglutide shortage resolved in late 2024 and the tirzepatide shortage resolved in early 2025, which tightened that window without ending all legitimate compounding activity. Compounded preparations are not identical to FDA-approved brand products and are priced on their own terms.

What you might actually pay

With a plan that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month, subject to plan caps. When the plan excludes the indication, cash cost lands near list price minus any coupon. Uninsured, expect to approach list price; compounded options through the PlexusDx Weight Management Protocols follow a separate published price structure. Note that PlexusDx offers semaglutide and tirzepatide protocols and does not sell or prescribe liraglutide.

The genetic layer under every GLP-1 decision

Whichever pathway compound you and your provider discuss, the biology beneath it is personal. The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights, reading variants such as FTO that shape appetite regulation and energy balance. It is educational and does not predict your response to any medication — it simply gives your provider more context.

Related reading on PlexusDx: Victoza for Weight Loss, Victoza Cost, and Injection Victoza.

Frequently Asked Questions

What is the monthly list price of liraglutide?

As of April 2026 it is roughly $815 per month at U.S. list price per Novo Nordisk published pricing. That is the pre-insurance figure; savings cards, plan coverage, and pharmacy pricing routinely change the counter total, so confirm the current amount with your pharmacy before filling.

Will my insurance help with liraglutide?

It depends on your plan's formulary, the FDA indication on the prescription, and prior-authorization criteria. Type 2 diabetes coverage is common in commercial plans; weight-management coverage varies widely. Medicare does not cover weight-alone indications as of April 2026. Confirm how your specific plan treats liraglutide before assuming any price.

Are discounts available?

Novo Nordisk offers a savings-card program for eligible commercially-insured patients, and platforms like GoodRx publish separate coupon prices. Patients on government insurance are usually excluded from manufacturer cards, so check the manufacturer site for current eligibility and caps at fill time.

Does PlexusDx offer liraglutide?

No. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, dispensed via licensed 503A compounding pharmacies. It does not sell, prescribe, or recommend liraglutide or other GLP-1 compounds outside those protocols; this article is educational only. Bring your questions about liraglutide to that provider consultation.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.